# The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance

> **NCT02329379** · PHASE4 · WITHDRAWN · sponsor: **Sheng-Chiang Su**

## Conditions studied

- Goiter

## Interventions

- **DRUG:** Levothyroxine

## Key facts

- **NCT ID:** NCT02329379
- **Lead sponsor:** Sheng-Chiang Su
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2015-12-31
- **Final completion:** 2015-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02329379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02329379, "The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02329379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*